{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:21:22Z","timestamp":1740162082040,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-021-00482-8","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T09:09:31Z","timestamp":1620724171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-5982","authenticated-orcid":false,"given":"Hidde L. A.","family":"Posthuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9e M.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Jos\u00e9","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieternella J.","family":"Lugtenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-6716","authenticated-orcid":false,"given":"Avinash G.","family":"Dinmohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"482_CR1","first-page":"1889","volume":"96","author":"I Anagnostopoulos","year":"2000","unstructured":"Anagnostopoulos, I. et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96, 1889\u20131899 (2000).","journal-title":"Blood"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","volume":"26","author":"L Nogov\u00e1","year":"2008","unstructured":"Nogov\u00e1, L. et al. Lymphocyte-predominant and classical Hodgkin\u2019s lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J. Clin. Oncol. 26, 434\u2013439 (2008).","journal-title":"J. Clin. Oncol."},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/0284186X.2019.1711166","volume":"59","author":"T Juntikka","year":"2020","unstructured":"Juntikka, T., Malila, N., Yl\u00f6stalo, T., Merikivi, M. & Jyrkki\u00f6, S. Epidemiology of classic and nodular lymphocyte predominant hodgkin lymphoma in Finland in 1996-2015. Acta Oncol. 59, 574\u2013581 (2020).","journal-title":"Acta Oncol."},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjh.16290","volume":"189","author":"HLA Posthuma","year":"2020","unstructured":"Posthuma, H. L. A. et al. Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016. Br. J. Haematol. 189, 117\u2013121 (2020).","journal-title":"Br. J. Haematol."},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/bjh.14567","volume":"177","author":"D Molin","year":"2017","unstructured":"Molin, D., Linderoth, J. & Wahlin, B. E. Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry. Br. J. Haematol. 177, 449\u2013456 (2017).","journal-title":"Br. J. Haematol."},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bjh.14861","volume":"182","author":"V Shivarov","year":"2018","unstructured":"Shivarov, V. & Ivanova, M. Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data. Br. J. Haematol. 182, 727\u2013730 (2018).","journal-title":"Br. J. Haematol."},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1182\/blood-2018-10-877761","volume":"133","author":"S Borchmann","year":"2019","unstructured":"Borchmann, S. et al. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 133, 2121\u20132129 (2019).","journal-title":"Blood"},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1200\/JCO.19.00986","volume":"38","author":"DA Eichenauer","year":"2020","unstructured":"Eichenauer, D. A. et al. Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. J. Clin. Oncol. 38, 698\u2013705 (2020).","journal-title":"J. Clin. Oncol."},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ije\/22.3.369","volume":"22","author":"LJ Schouten","year":"1993","unstructured":"Schouten, L. J., H\u00f6ppener, P., van den Brandt, P. A., Knottnerus, J. A. & Jager, J. J. Completeness of cancer registration in Limburg, The Netherlands. Int. J. Epidemiol. 22, 369\u2013376 (1993).","journal-title":"Int. J. Epidemiol."},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris, N. L. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361\u201392. (1994).","journal-title":"Blood"},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2796.2006.01677.x","volume":"260","author":"PW Dickman","year":"2006","unstructured":"Dickman, P. W. & Adami, H. O. Interpreting trends in cancer patient survival. J. Intern. Med. 260, 103\u2013117 (2006).","journal-title":"J. Intern. Med."},{"key":"482_CR12","first-page":"101","volume":"6","author":"F Ederer","year":"1961","unstructured":"Ederer, F., Axtell, L. M. & Cutler, S. J. The relative survival rate: a statistical methodology. Natl Cancer Inst. Monogr. 6, 101\u2013121 (1961).","journal-title":"Natl Cancer Inst. Monogr."},{"key":"482_CR13","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.ejca.2004.07.022","volume":"40","author":"H Brenner","year":"2004","unstructured":"Brenner, H. & Rachet, B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur. J. Cancer 40, 2494\u20132501 (2004).","journal-title":"Eur. J. Cancer"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever, D. & Diehl, V. A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N. Engl. J. Med. 339, 1506\u20131514 (1998).","journal-title":"N. Engl. J. Med."},{"key":"482_CR15","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1200\/JCO.2009.25.9697","volume":"28","author":"ML Janssen-Heijnen","year":"2010","unstructured":"Janssen-Heijnen, M. L. et al. Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J. Clin. Oncol. 28, 2520\u20132528 (2010).","journal-title":"J. Clin. Oncol."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00482-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:44:46Z","timestamp":1669909486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00482-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1038\/s41408-021-00482-8","relation":{},"ISSN":["2044-5385"],"issn-type":[{"type":"electronic","value":"2044-5385"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"87"}}